November 5–7, 2025 | Goodenough College, London, UK

We are pleased to announce that the International Neurotransmitter Disorders Conference (INDConf 2025) will take place from November 5 to 7, 2025, at Goodenough College in London.

This international event brings together experts, researchers, and families for three days of learning, sharing, and connection. We look forward to welcoming families and professionals working to improve lives affected by neurotransmitter disorders.

Hrabriša – Lil’ Brave One is offering a limited number of sponsorships for families of children diagnosed with rare neurotransmitter disorders. 

This sponsorship is proudly supported by the Patient Organization for Rare Neurotransmitter Diseases – Hrabriša - Lil’ Brave One and has been made possible in part by grant 2024-347839 from the Chan Zuckerberg Initiative DAF, an advised fund of Silicon Valley Community Foundation.

Special Workshop for Families – Join the Conversation! As part of the conference, a dedicated Neurotransmitter Workshop for Patient & Public Engagement will take place on:

Friday, November 7, 2025
Location: Goodenough College, London

Hrabriša – Lil’ Brave One, in partnership with the TakT Center and with the support of the “For an active civil society together” project and Phoenix company, is launching a new cycle of emotional and psychological support for parents through the program “Our Story.”

Who is the program for?

The program is intended for parents of children with rare neurotransmitter diseases, developmental disorders, or chronic non-communicable conditions, regardless of the child’s age, and the type or severity of the condition.

The story of children in Serbia living with ultra-rare neurotransmitter diseases (RNDs) reached Las Vegas this May 2025, thanks to the patient organization Hrabriša – Lil’ Brave One. 

The organization focuses on improving the lives of children affected by this group of rare disorders. It has become the only patient group from Southeast Europe to join the Rare As One network, supported by the Chan Zuckerberg Initiative (CZI).

With this support, Lil’ Brave One (Hrabrisa) is working to develop a cross-border network of researchers and clinicians, experts in these still largely unknown conditions.